Alexander Rodriguez, Dr Jasna Aleksova and Prof Peter Ebeling at the AMZBMS scientific meeting |
School of Clinical Sciences at Monash Health PhD students Alexander
Rodriguez and Dr Jasna Aleksova received prestigious awards from the Australia
New Zealand Bone and Mineral Society (ANZBMS) in Brisbane last week.
Alexander received the 2017 Christine & T. Jack Martin
Research Travel Grant, an award in memory of Christine Martin that also honours
the outstanding and major scientific contributions of Professor T. Jack Martin
to bone and mineral research.
Alexander will use the $15,000 grant to travel to
Odense, Denmark to work with Professor Bo Abrahamsen from the University of
Southern Denmark.
“My current research investigates how bone and muscle loss can
effect cardiovascular risk in old age, and I plan to collaborate with Professor
Abrahamsen to examine how anti-osteoporosis therapies, which we think are
helping us by making our bones healthier, may actually have harmful cardiovascular
side-effects,” Alexander said.
“I hope that this research will enable us to identify who is at
least cardiovascular risk from these medications and thus avoid potential
adverse events whilst still remaining on osteoporosis treatment.”
Alexander’s supervisor and Head, Department of Medicine Professor
Peter Ebeling AO said this research comes at a critical time, as two
anti-osteoporosis drugs, strontium ranelate and odanacatib, have recently been
withdrawn from the market because of cardiovascular safety concerns.
“Alexander’s research will help us understand who may be better
suited to the many different treatment options available and by targeting
therapy to increase benefit and to reduce potential harm,” Professor Ebeling
said.
Fellow PhD student in the Bone and Muscle Research Group and Monash
Health Endocrinologist, Dr Jasna Aleksova, won the Professor Philip Sambrook
Young Investigator Travel Award which is awarded to an outstanding early career
scientist or clinical researcher.
Dr Aleksova’s research evaluates novel risk factors associated
with fractures in patients with chronic kidney disease (CKD) and those with
kidney transplants.
“These patients have a high burden of fractures and associated
mortality, however, the current diagnostic tools used to evaluate patients with
osteoporosis are less useful in patients with CKD,” Dr Aleksova said.
“CKD now affects one in ten Australians so urgent strategies are
needed to identify and treat those at highest risk of fracture.”
“My research focuses on the role of hypogonadism in CKD and
post-transplantation and the validation of novel imaging techniques, including
the trabecular bone score and structural hip analyses, to better predict
patients who are at the greatest risk of fracture,” she said.
Dr. Aleksova will use this grant to present some of her work at
the American Society for Bone and Mineral Research annual meeting in Denver
later this year where she will also be meeting with potential collaborators
from Columbia University.
Senior Research Fellow Dr David Scott also from the Bone and
Muscle Research Group had his abstract ‘Sarcopenic obesity is associated
with lower tibial cortical area and thickness and poor physical function in
community-dwelling older adults’ selected for an oral presentation at the
ANZBMS scientific meeting last week.
Dr Scott said his study demonstrates that important indicators of
bone quality, which are usually improved in obese individuals, may be
compromised if muscle quality is also poor.
“The findings highlight the need for specific assessments and
interventions to target bone health in obese older adults,” Dr Scott said.
No comments:
Post a Comment